<code id='578E835F28'></code><style id='578E835F28'></style>
    • <acronym id='578E835F28'></acronym>
      <center id='578E835F28'><center id='578E835F28'><tfoot id='578E835F28'></tfoot></center><abbr id='578E835F28'><dir id='578E835F28'><tfoot id='578E835F28'></tfoot><noframes id='578E835F28'>

    • <optgroup id='578E835F28'><strike id='578E835F28'><sup id='578E835F28'></sup></strike><code id='578E835F28'></code></optgroup>
        1. <b id='578E835F28'><label id='578E835F28'><select id='578E835F28'><dt id='578E835F28'><span id='578E835F28'></span></dt></select></label></b><u id='578E835F28'></u>
          <i id='578E835F28'><strike id='578E835F28'><tt id='578E835F28'><pre id='578E835F28'></pre></tt></strike></i>

          hotspot

          hotspot

          author:entertainment    Page View:73544
          microbiome runners
          Adobe

          Elite athletes really are different from you and me. Or, at least their gut microbes are.

          Scientists who analyzed stool samples of 15 runners a week before and after they competed in the 2015 Boston Marathon found unusually high levels of one particular microbe compared to 10 non-athletes. Levels of the microbe in question, Veillonella, spiked after an intense workout and bloomed even more after the marathon.

          advertisement

          That was a lightbulb moment for the scientists because the bacterium is known for breaking down and eating lactate, a metabolite even ordinary runners equate with fatigue.  

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati
          In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

          CourtesyBristolMyersSquibbBristolMyersSquibbsaidthatitwouldpurchaseMiratiTherapeutics,makerofthecanc

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          FDA rejects Alnylam's heart disease treatment over insufficient data

          KristofferTripplaar/SipaUSA/APTheFoodandDrugAdministrationrejectedanAlnylamPharmaceuticals’therapyfo